BPA for xipere
Ended Awarded Last action
- Contract number
- 36E79722A0021
- Awardee
-
Bausch & Lomb Americas Inc. UEI L753GSBUD9K6
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $617,550.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Bausch & Lomb Americas Inc. as a single-award contract with a potential value of $617,550. The BPA is for the procurement of XIPERE to treat macular edema following retinal vein occlusion. No set-aside was used. Delivery orders may be placed under this BPA through September 2022 to acquire the drug from the prime contractor for use at Veterans Affairs medical facilities nationwide in accordance with the original solicitation and Statement of Work. XIPERE, also known as triamcinolone acetonide injectable suspension, is an intravitreal implant used to treat two eye conditions characterized by swelling of the macula which can cause vision loss if left untreated. This BPA streamlines the acquisition process for this important medication to support the treatment of eligible veterans.
The Department of Veterans Affairs National Acquisition Center awarded Bausch & Lomb Americas Inc. a single-award Blanket Purchase Agreement with a potential value of $617,550 to procure the drug XIPERE, also known as triamcinolone acetonide injectable suspension, for use at Veterans Affairs medical facilities nationwide. The BPA utilizes no set-aside and permits placement of delivery orders through September 2022 for this intravitreal implant, which treats macular edema following retinal vein occlusion as well as other eye conditions involving macular swelling that can lead to vision loss if left untreated. This contract vehicle facilitates efficient procurement of this important medication to support the vision care needs of eligible veterans as outlined in the original solicitation and Statement of Work.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79722A0021?
36E79722A0021 was awarded to Bausch & Lomb Americas Inc. by National Acquisition Center (Headquarters) on May 21, 2022.
How much is contract 36E79722A0021 worth?
36E79722A0021's own ceiling is $617,550.
Who can order from contract 36E79722A0021?
36E79722A0021 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0021 under another contract?
Yes. 36E79722A0021 is a blanket purchase agreement under 36F79722D018E, a federal supply schedule.
Was contract 36E79722A0021 competed?
The extent of competition for 36E79722A0021 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV